TRICOPAT™ is the latest development in trichology for the treatment of male and female scalp pathologies, in a completely painless way and without injections.
The device uses the unique TRICOGENESI™ methodology, which is backed by 2 global patents and marks an innovation that is 100% Italian.
The result of over 15 years of experience in the field of dermatology, TRICOPAT™ was developed thanks to a research project performed at the Scientific and Technological Hub that is home to CNR, ENEA and the University of Bologna.
TRICOPAT™ technology combines the simultaneous action of skin micro-incision and
pressure waves to perform various dynamic restructuring actions:
- Immediate increase of blood microcirculation for tissue oxygenation
- Stimulation of the tissue’s cellular metabolism
- Delivery of active ingredients
TRICOPAT™ concentrates several dynamic restructuring actions in a single portable device weighing just 4.5 kg, including:
- Controlled skin micro-incision
- Pressure wave stimulation
TRICOGENESI™ methodology is developed by the association of TRICOPAT™ and growth factors vehiculated with iontophoresis.
The result is a significant improvement of androgenetic alopecia both in male and female patients, with reduction of hair loss and an increased hair diameter in all the treated scalp areas.